Company profile: Deep 6 AI
1.1 - Company Overview
Company description
- Provider of an AI-powered clinical research platform that mines EMR data and analyzes structured data (e.g., ICD-10 codes) and unstructured clinical data (doctor's notes, pathology reports, operating notes) to match patients to trials, accelerate recruitment, assess trial feasibility and optimize study design, select sites, monitor enrollment in real time with physician workflow integration, and deliver post-study performance insights.
Products and services
- Trial Design and Feasibility: AI-powered system that analyzes real-world data, ICD-10 codes, and unstructured doctor’s notes, pathology reports, and operating notes to architect optimized protocols and rigorously assess study feasibility
- Patient Recruitment: AI-driven EMR-mining platform that matches eligible patients to clinical trials by interpreting ICD-10 codes, doctor’s notes, pathology reports, and operating notes, dramatically compressing recruitment timelines
- Site Selection: FDA-policy-aware software that pinpoints trial sites with sufficient patient populations by evaluating demographics and FDA policies to align study placement with population availability
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Deep 6 AI
Compendia Bioscience
HQ: United States
Website
- Description: Provider of cancer genomics solutions for oncology research, including bioinformatics to prioritize and annotate driver variants and link biomarkers to curated knowledge; reporting that connects biomarkers to therapies, guidelines, and clinical trials; targeted NGS assays with PCR-based library prep; liquid biopsy tools using cfDNA/ctDNA/CTCs with digital PCR/NGS; and whole exome sequencing via Ion Proton.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Compendia Bioscience company profile →
Alcedis
HQ: Germany
Website
- Description: Provider of digital clinical research services, including comprehensive trial management from phase I to approval, real-world evidence collection, and scientific consulting. Delivers platforms for multi-channel data integration with customized eCRFs, mobile applications, and big data interfaces, plus regulatory-compliant study design, technology integration to maximize data quality, and full study conduct.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alcedis company profile →
Nexus Biosystems
HQ: United States
Website
- Description: Provider of technologies and automation systems for pharmaceutical, biotech, agrochemical, and academic research institutions internationally, offering Universal Store, a sample storage and retrieval system, and IRORI technologies for directed sorting and cleaving of solid-phase combinatorial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nexus Biosystems company profile →
IMS
HQ: United States
Website
- Description: Provider of analytic services, data management, application development, web services, and cloud computing and hosting support, with 40+ years of IT and clinical trials experience. Develops software products and web applications supporting biomedical research for clients including the National Cancer Institute, the Centers for Disease Control and Prevention, and major pharmaceutical firms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMS company profile →
Author-it
HQ: United States
Website
- Description: Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Author-it company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Deep 6 AI
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Deep 6 AI
2.2 - Growth funds investing in similar companies to Deep 6 AI
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Deep 6 AI
4.2 - Public trading comparable groups for Deep 6 AI
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →